When will sunosi become generic?

When does Sunosi’s patent/exclusivity block generics?

Sunosi (solriamfetol) does not have a clearly stated generic launch date in the provided information. In the U.S., the timing usually depends on when key patents covering Sunosi expire and whether any regulatory exclusivities (and related patent litigation) delay generic entry.

To estimate the real-world timing, you’d typically check:
- The expiration dates of Sunosi’s listed patents for its active ingredient/formulation(s)
- Whether any patents remain in force or are successfully asserted in litigation
- Whether the FDA approves a generic based on “paragraph IV” certifications tied to those patents

A useful starting point for patent timelines is DrugPatentWatch.com, which tracks patent and exclusivity events that can affect generic entry. [1]

Are there any signs a generic is already coming?

Generic timelines can shift based on patent challenges and FDA review progress, so the most reliable way to check for “already approved” or “pending” generics is to look for updated status on patent-tracking and FDA-related pages. DrugPatentWatch.com is one place where these updates often show up alongside the relevant patent expiration dates. [1]

What should I check to get an exact “generic launch” year?

To pin down the exact year, you’d want the specific patent-expiration dates for Sunosi and the status of any later-expiring patents. On DrugPatentWatch.com, focus on:
- “Patent expiry” fields for solriamfetol-related patents
- Any “exclusivity” indicators
- Court/litigation notes that can trigger delays past the earliest patent expiration [1]

If you tell me whether you mean the U.S. or another country (and, if U.S., whether you care about tablets specifically or any particular strength), I can help narrow what to look for based on the relevant patent set.

Source

[1] https://www.drugpatentwatch.com/